Biodelivery sciences to participate in the piper sandler 32nd annual healthcare conference

Raleigh, n.c., nov. 20, 2020 (globe newswire) -- biodelivery sciences international, inc. (nasdaq: bdsi), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that jeff bailey, chief executive officer, and terry coelho, chief financial officer, will participate in a fireside chat and 1x1 investor meetings at the piper sandler 32nd annual healthcare conference.
BDSI Ratings Summary
BDSI Quant Ranking